Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma

BACKGROUND: Approximately 50% of patients with uveal melanoma (UM) will develop metastatic disease, usually involving the liver. The outcome of metastatic UM (mUM) is generally poor and no standard therapy has been established. Additionally, clinicians lack a validated prognostic tool to evaluate th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Valpione, Sara, Moser, Justin C., Parrozzani, Raffaele, Bazzi, Marco, Mansfield, Aaron S., Mocellin, Simone, Pigozzo, Jacopo, Midena, Edoardo, Markovic, Svetomir N., Aliberti, Camillo, Campana, Luca G., Chiarion-Sileni, Vanna
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363319/
https://ncbi.nlm.nih.gov/pubmed/25780931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120181
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars